A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...

From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...

At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets. Danish techbio company Evaxion Biotech has published results ...

George White is the General Manager of Cell Therapy at Cytiva, a global biomanufacturing organization headquartered in the U.S. and part of Danaher. In this Q&A with Biopharma Reporter, White ...

The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront payments. AviadoBio was founded in London in 2019 based on research carried ...